Provided by Tiger Trade Technology Pte. Ltd.

Agree

72.25
-0.6830-0.94%
Post-market: 72.250.00000.00%19:46 EDT
Volume:1.23M
Turnover:89.34M
Market Cap:8.99B
PE:39.02
High:73.15
Open:73.00
Low:72.21
Close:72.93
52wk High:82.08
52wk Low:69.56
Shares:124.38M
Float Shares:122.18M
Volume Ratio:1.30
T/O Rate:1.01%
Dividend:3.14
Dividend Rate:4.35%
EPS(TTM):1.85
EPS(LYR):1.77
ROE:3.70%
ROA:2.40%
PB:1.42
PE(LYR):40.82

Loading ...

Press Release: OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights

Dow Jones
·
Aug 07

Press Release: NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 07

Whitehawk’s HWK-016 ADC Trial Advances in Tough Ovarian and Endometrial Cancers

TIPRANKS
·
Aug 07

Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap As ADC Pipeline News Builds?

Simply Wall St.
·
Aug 06

Press Release: Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Dow Jones
·
Aug 06

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
Aug 06

Press Release: Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates

Dow Jones
·
Aug 06

Hong Kong Stock Moves: SKB BIO Surges Over 4% Before Noon as New Dual-Load ADC Drug Gets Clinical Trial Approval

Stock News
·
Aug 06

Agree Realty Releases Transcript of Q2 2026 Earnings Call

Reuters
·
Aug 05

Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation

GlobeNewswire
·
Aug 04

Yomiuri: Japan, Mexico Agree to Expand Bilateral Cooperation on Economic Security, Energy

Dow Jones
·
Aug 04

Hong Kong Market Move: BIOCYTOGEN-B Surges Over 10% on Dual Antibody ADC Overseas Expansion, Preclinical CRO and Model Mouse Segments See Rising Momentum

Stock News
·
Aug 04

ALPHAMAB-B Surges Over 12% in Morning Trade Following $2.1 Billion TROP2/HER3 Dual Antibody ADC Export Licensing Deal

Deep News
·
Aug 04

Adlai Nortye Initiated at Buy as First-in-Class RASiCA ADC Enters Clinic; $20 Price Target Reiterated

TIPRANKS
·
Aug 04

BofA Securities Adjusts Agree Realty Price Target to $93 From $92

MT Newswires Live
·
Aug 03

How Investors Are Reacting To Agree Realty (ADC) Earnings Growth Outpacing Diluted EPS Gains

Simply Wall St.
·
Aug 03

SBP Group's Third Breakthrough Therapy Designation for TQB2102 Strengthens Its Position in HER2-Targeted Cancer Treatments

Stock News
·
Aug 03

Hong Kong Stock Moves: Biocytogen-B Surges Over 8% Afternoon Following Whitehawk Deal, Five Bispecific ADC Candidates Going Global

Stock News
·
Aug 03

Can Agree Realty (ADC) Justify Its Valuation Following Raised Guidance And A Dividend Increase?

Simply Wall St.
·
Aug 02

How Much Should an AI Agent Cost? no One Can Agree - and It's Creating Chaos.

Dow Jones
·
Aug 01